HIMS & HERS HEALTH INC

HIMS stock represents ownership shares in Hims & Hers Health, Inc., a U.S.-based telehealth and consumer wellness company. Its Class A common stock trades on the New York Stock Exchange under the ticker HIMS. As a publicly listed company, Hims & Hers provides investors with exposure to a digital-first model focused on making personal health and wellness products and services more accessible. The stock's price and market data change continuously during trading hours, so investors should refer to the latest HIMS quote and profile displayed on the page for current details.

HIMS operates primarily within the telehealth, digital health, and consumer wellness industry. Its platforms connect users with licensed healthcare providers and offer access to prescription treatments and personal care products across categories such as dermatology, sexual health, mental health, and weight management. Because it blends healthcare services, pharmacy fulfillment, and direct-to-consumer e-commerce, HIMS is often grouped with digital health companies or healthcare technology firms. This positioning means its performance can be influenced by both healthcare trends and consumer discretionary spending.

The most current HIMS stock price is shown in the quote section of this page, along with the day's change and trading volume. That display reflects the latest market data available and is the appropriate place to check for real-time or near real-time pricing. You can also look at the listed exchange, the New York Stock Exchange, through brokerage platforms or financial data providers. Because the price changes throughout the trading session, any figure mentioned in commentary or news may already be out of date compared with the live quote.

The volatility of HIMS stock can be assessed by reviewing its historical price movements, daily percentage swings, and the 52-week range shown on the page. Stocks of growing telehealth and consumer health companies often experience larger price movements than more established, diversified businesses, particularly around earnings releases, guidance updates, or regulatory news. For the latest volatility characteristics, investors should examine the current HIMS charts, trading volume, and the 52-week high and low displayed in the page data rather than relying on fixed figures that may become outdated.

Analyzing HIMS financial performance typically involves reviewing quarterly and annual reports, including the income statement, balance sheet, and cash flow statement. Revenue growth, customer growth, gross margin, operating expenses, and profitability metrics such as net income or adjusted EBITDA can help investors understand the trend of the business. Segment or product-level disclosures, if available, may show which areas are growing fastest. These figures are reported by the company on a regular schedule, so investors should compare the latest official filings rather than relying on estimates or summaries.

Key risks for HIMS include regulatory changes affecting telehealth and prescription sales, competitive pressure from other digital health platforms and traditional healthcare providers, and reliance on customer acquisition and retention. Its business may also be sensitive to consumer spending trends, pharmacy or supply chain disruptions, and evolving data privacy rules. Because HIMS is a growth-oriented company, its stock can react sharply to changes in growth expectations or profitability. Investors should review the risk factors in HIMS's annual and quarterly filings, which provide a detailed, company-specific discussion of these risks.